Indicators of cytokine markers in patients with cardiovascular diseases
https://doi.org/10.37489/0235-2990-2024-69-3-4-58-61
EDN: VNUYPK
Abstract
A study of interleukin-1β, interleukin-10, and CD40 ligand (CD40L) parameters in patients with arterial hypertension (AH), coronary heart disease (CHD), including cardiac arrhythmias (CA), was carried out. The study included 90 patients, divided into 3 groups (AH, CHD, CHD + CA). The results of the study demonstrated the possible involvement of an inflammatory cytokine, interleukin-1, in the development of AH, the level of which in our study significantly increased with the addition of such cardiovascular complications as heart failure (HF), CHD, including CHD with CA.
About the Authors
D. Kh. Kushkhova
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Diana Kh. Kushkhova — 6th year student majoring in General Medicine
Nalchik
Z. A. Kambachokova
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Zareta A. Kambachokova — D. Sc. in Medicine, Professor of the Department of Hospital Therapy
Nalchik
S. I. Miziev
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Suleiman I. Miziev — 6th year student majoring in General Medicine
Nalchik
Kh. A. Temirsultanova
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Khava A. Temirsultanova — 6th year student majoring in General Medicine
Nalchik
M. V. Makhmaeva
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Makka V. Makhmaeva — 6th year student majoring in General Medicine
Nalchik
A. Kh. Khatsukova
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Alina Kh. Khatsukova — 6th year student majoring in General Medicine
Nalchik
S. M. Bakhalaeva
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Selima M. Bakhalaeva — 6th year student majoring in General Medicine
Nalchik
D. R. Artskhaeva
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Dana R. Artskhaeva — 6th year student majoring in General Medicine
Nalchik
M. R. Kushkhov
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Murat R. Kushkhov — 6th year student majoring in General Medicine
Nalchik
D. Z. Soblirova
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Diana Z. Soblirova — 6th year student majoring in General Medicine
Nalchik
F. Kh. Karova
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Fardaus Kh. Karova — 6th year student majoring in General Medicine
Nalchik
A. Ch. Mamkhegova
Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Russian Federation
Aiza Ch. Mamkhegova — 6th year student majoring in General Medicine
Nalchik
References
1. Adawi A., Zhang Y., Baggs R. et al. Disruption of the CD40–CD40l system prevents an oxygeninduced distress syndrome. Am J Pathol. 1998; 152 (3): 651–657.
2. Amir O., Rogowski O., David M. et al. Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha. Isr Med Assoc J. 2010; 12(3): 158–162.
3. Miettinen K.H., Lassus J., Harjola V.P. et al. Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail. 2008; 10 (4): 396–403. doi: 10.1016/j.ejheart.2008.02.008.
4. Myrianthefs P.M., Lazaris N., Venetsanou K. et al. Immune status evaluation of patients with chronic heart failure. Cytokine. 2007; 37 (2): 150–154. doi: 10.1016/j.cyto.2007.03.007.
5. Oikonomou E., Tousoulis D., Siasos G. et al. The role of inflammation in heart failure: new therapeutic approaches. Hellenic J Cardiol. 2011; 52 (1): 30–40.
6. Pasqui A.L., Di Renzo M., Maffei S. et al. Pro/Anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling. Mediators Inflamm. 2010; 2010: 974694. doi: 10.1155/2010/974694.
7. Pierson W., Liston A. A new role for interleukin-10 in immuneregulation. Immunol Cell Biol. 2010; 88 (8): 769–770. doi: 10.1038/icb.2010.105.
8. Kalogeropoulos A.P., Georgiopoulou V.V., Butler J. From risk factors to structural heart disease: the role of inflammation. Heart Fail Clin. 2012; 8 (1): 113–123. doi: 10.1016/j.hfc.2011.08.002.
9. Kaur K., Dhingra S., Slezak J. et al. Biology of TNFalpha and IL-10, and their imβalance in heart failure. Heart Fail Rev. 2009; 14 (2): 113–123. doi: 10.1007/s10741-008-9104-z.
10. Kooten C., Banchereau J. CD40-CD40ligand/ C. Kooten, J. Banchereau. J Leikocyte Biology. 2000; 2–13.
11. Lindberg E., Magnusson Y., Karason K., Andersson B. Lower levels of the host protective IL-10 in DCM-a feature of autoim-mune pathogenesis? Autoimmunity. 2008; 41 (6): 478–483. doi: 10.1080/08916930802031645.
12. Дедкова А.А., Кологривова И.В., Суслова Т.Е., Баталов Р.Е., Борисова Е.В. Значение процессов воспаления в патогенезе фибрилляции предсердий у пациентов с ишемической болезнью сердца. Сибирский медицинский журнал. 2015; 30(1): 40–43. [Dedkova A.A., Kologrivova I.V., Suslova T.E., Batalov R.E., Borisova E.V. Znachenie protsessov vospaleniya v patogeneze fibrillyatsii predserdij u patsientov s ishemicheskoj bolezn'jyu serdtsa. Sibirskij Meditsinskij Zhurnal. 2015; 30(1): 40–43. (in Russian)]
13. Heymans S., Hirsch E., Anker S.D. et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009; 11 (2): 119–129. doi: 10.1093/eurjhf/hfn043.
Review
For citations:
Kushkhova D.Kh., Kambachokova Z.A., Miziev S.I., Temirsultanova Kh.A., Makhmaeva M.V., Khatsukova A.Kh., Bakhalaeva S.M., Artskhaeva D.R., Kushkhov M.R., Soblirova D.Z., Karova F.Kh., Mamkhegova A.Ch. Indicators of cytokine markers in patients with cardiovascular diseases. Antibiot Khimioter = Antibiotics and Chemotherapy. 2024;69(3-4):58-61. (In Russ.) https://doi.org/10.37489/0235-2990-2024-69-3-4-58-61. EDN: VNUYPK
Views:
362
Email this article 